Preface

Head and neck cancers comprise a unique set of distinct disease entities, from carcinogen-related and viral-mediated mucosal cancers to the rare salivary gland malignancies, all of which necessitate multidisciplinary expert collaboration to diagnose and treat. In the last few years, there have been important advances made within the head and neck oncology community. This often underrecognized and highly specialized area of cancer medicine has been revolutionized by the established benefits of immunotherapy in the advanced disease setting, and we have made further strides toward treatment deintensification while preserving favorable outcomes in human papillomavirus (HPV)-associated disease.
Source: Hematology/Oncology Clinics of North America - Category: Cancer & Oncology Authors: Source Type: research